Adcentrx Therapeutics Funding & Investors
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.
adcentrx.comTotal Amount Raised: $101,000,000
Adcentrx Therapeutics Funding Rounds
Series A
$51,000,000
Series A Investors
Eight Roads VenturesTrinity Innovation FundF-PrimeLIGHTHOUSEDelta CapitalABio-XQuan CapitalPartners InvestmentSeries A
$50,000,000
Series A Investors
C-Bridge CapitalZoo CapitalCBC Group
Funding info provided by Diffbot.